Slideshow
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Impavido_2015
-
Slide
-
Slide
-
Slide
-
Slide
Twenty-five of the 2014 novel new drugs were designated Priority Review, in which the FDA determined the drug to potentially provide a significant advance in medical care.